|
Amisulpride (brand name Solian®) is an antipsychotic sold by Sanofi laboratories.
Amisulpride occurs as selective dopamine antagonist. Its dose ranges from either 200 to 1200 mg/day.
When for currently, Amisulpride is non approved per FDA for use in the United States.
Reported side results: Parkinsonism, Weight gain.
|
Focus on Amisulpride (Solian)
Review of the pharmacology, efficacy, contraindications, side effects, and other aspects of this antipsychotic medication.
|
© 2005 GeneralAnswers.org |
|